These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

236 related articles for article (PubMed ID: 22038335)

  • 1. C-reactive protein as a predictor of cardiovascular events in elderly patients with chronic kidney disease.
    Jalal D; Chonchol M; Etgen T; Sander D
    J Nephrol; 2012; 25(5):719-25. PubMed ID: 22038335
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Low High-Sensitivity C-Reactive Protein Level in Korean Patients With Chronic Kidney Disease and Its Predictive Significance for Cardiovascular Events, Mortality, and Adverse Kidney Outcomes: Results From KNOW-CKD.
    Lee C; Park KH; Joo YS; Nam KH; Chang TI; Kang EW; Lee J; Oh YK; Jung JY; Ahn C; Lee KB; Park JT; Yoo TH; Kang SW; Han SH
    J Am Heart Assoc; 2020 Nov; 9(21):e017980. PubMed ID: 33092438
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Plasma ceruloplasmin, a regulator of nitric oxide activity, and incident cardiovascular risk in patients with CKD.
    Kennedy DJ; Fan Y; Wu Y; Pepoy M; Hazen SL; Tang WH
    Clin J Am Soc Nephrol; 2014 Mar; 9(3):462-7. PubMed ID: 24311705
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cumulative Exposure to High-Sensitivity C-Reactive Protein Predicts the Risk of Cardiovascular Disease.
    Wang A; Liu J; Li C; Gao J; Li X; Chen S; Wu S; Ding H; Fan H; Hou S
    J Am Heart Assoc; 2017 Oct; 6(10):. PubMed ID: 29066453
    [TBL] [Abstract][Full Text] [Related]  

  • 5. C reactive protein and long-term risk for chronic kidney disease: a historical prospective study.
    Kugler E; Cohen E; Goldberg E; Nardi Y; Levi A; Krause I; Garty M; Krause I
    J Nephrol; 2015 Jun; 28(3):321-7. PubMed ID: 24981713
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Serum Albumin and High-Sensitivity C-reactive Protein are Independent Risk Factors of Chronic Kidney Disease in Middle-Aged Japanese Individuals: the Circulatory Risk in Communities Study.
    Kubo S; Kitamura A; Imano H; Cui R; Yamagishi K; Umesawa M; Muraki I; Kiyama M; Okada T; Iso H;
    J Atheroscler Thromb; 2016 Sep; 23(9):1089-98. PubMed ID: 26911856
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The association between C-reactive protein levels and the risk for chronic kidney disease hospitalizations in adults of a remote Indigenous Australian community - A prospective cohort study.
    Arnold LW; Hoy WE; Wang Z
    Nephrology (Carlton); 2017 Sep; 22(9):699-705. PubMed ID: 27312245
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Association of serum chloride level with mortality and cardiovascular events in chronic kidney disease: the CKD-ROUTE study.
    Mandai S; Kanda E; Iimori S; Naito S; Noda Y; Kikuchi H; Akazawa M; Oi K; Toda T; Sohara E; Okado T; Sasaki S; Rai T; Uchida S
    Clin Exp Nephrol; 2017 Feb; 21(1):104-111. PubMed ID: 27039905
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Disparities in the Estimation of Glomerular Filtration Rate According to Cockcroft-Gault, Modification of Diet in Renal Disease-4, and Chronic Kidney Disease Epidemiology Collaboration Equations and Relation With Outcomes in Patients With Acute Coronary Syndrome.
    Rivera-Caravaca JM; Ruiz-Nodar JM; Tello-Montoliu A; Esteve-Pastor MA; Quintana-Giner M; Véliz-Martínez A; Orenes-Piñero E; Romero-Aniorte AI; Vicente-Ibarra N; Pernias-Escrig V; Carrillo-Alemán L; Candela-Sánchez E; Hortelano I; Villamía B; Sandín-Rollán M; Nuñez-Martínez L; Valdés M; Marín F
    J Am Heart Assoc; 2018 Apr; 7(9):. PubMed ID: 29680822
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Amino-terminal pro-B-type natriuretic peptide and high-sensitivity C-reactive protein but not cystatin C predict cardiovascular events in male patients with peripheral artery disease independently of ambulatory pulse pressure.
    Skoglund PH; Arpegård J; Ostergren J; Svensson P
    Am J Hypertens; 2014 Mar; 27(3):363-71. PubMed ID: 24470529
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impact of Chronic Kidney Disease on Cardiovascular and Renal Events in Patients Undergoing Percutaneous Coronary Intervention with Everolimus-Eluting Stent: Risk Stratification with C-Reactive Protein.
    Dan K; Miyoshi T; Nakahama M; Mizuno T; Kagawa K; Naito Y; Kawada S; Ito H
    Cardiorenal Med; 2018; 8(2):151-159. PubMed ID: 29617004
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Relative Prognostic Value of Cardiac Troponin I and C-Reactive Protein in the General Population (from the Nord-Trøndelag Health [HUNT] Study).
    Sigurdardottir FD; Lyngbakken MN; Holmen OL; Dalen H; Hveem K; Røsjø H; Omland T
    Am J Cardiol; 2018 Apr; 121(8):949-955. PubMed ID: 29496193
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Six-year change in high-sensitivity C-reactive protein and risk of diabetes, cardiovascular disease, and mortality.
    Parrinello CM; Lutsey PL; Ballantyne CM; Folsom AR; Pankow JS; Selvin E
    Am Heart J; 2015 Aug; 170(2):380-9. PubMed ID: 26299237
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The relationship between IL-10 levels and cardiovascular events in patients with CKD.
    Yilmaz MI; Solak Y; Saglam M; Cayci T; Acikel C; Unal HU; Eyileten T; Oguz Y; Sari S; Carrero JJ; Stenvinkel P; Covic A; Kanbay M
    Clin J Am Soc Nephrol; 2014 Jul; 9(7):1207-16. PubMed ID: 24789549
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of the Association Between High-Sensitivity Troponin I and Adverse Cardiovascular Outcomes in Patients With Versus Without Chronic Kidney Disease.
    Sandesara PB; O'Neal WT; Tahhan AS; Hayek SS; Lee SK; Khambhati J; Topel ML; Hammadah M; Alkhoder A; Ko YA; Gafeer MM; Beshiri A; Murtagh G; Kim JH; Wilson P; Shaw L; Epstein SE; Sperling LS; Quyyumi AA
    Am J Cardiol; 2018 Jun; 121(12):1461-1466. PubMed ID: 29628129
    [TBL] [Abstract][Full Text] [Related]  

  • 16. C-reactive protein predicts future cardiovascular events in patients with carotid stenosis.
    Schlager O; Exner M; Mlekusch W; Sabeti S; Amighi J; Dick P; Wagner O; Koppensteiner R; Minar E; Schillinger M
    Stroke; 2007 Apr; 38(4):1263-8. PubMed ID: 17322087
    [TBL] [Abstract][Full Text] [Related]  

  • 17. GDF-15, Galectin 3, Soluble ST2, and Risk of Mortality and Cardiovascular Events in CKD.
    Tuegel C; Katz R; Alam M; Bhat Z; Bellovich K; de Boer I; Brosius F; Gadegbeku C; Gipson D; Hawkins J; Himmelfarb J; Ju W; Kestenbaum B; Kretzler M; Robinson-Cohen C; Steigerwalt S; Bansal N
    Am J Kidney Dis; 2018 Oct; 72(4):519-528. PubMed ID: 29866459
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prognostic significance of the Centers for Disease Control/American Heart Association high-sensitivity C-reactive protein cut points for cardiovascular and other outcomes in patients with stable coronary artery disease.
    Sabatine MS; Morrow DA; Jablonski KA; Rice MM; Warnica JW; Domanski MJ; Hsia J; Gersh BJ; Rifai N; Ridker PM; Pfeffer MA; Braunwald E;
    Circulation; 2007 Mar; 115(12):1528-36. PubMed ID: 17372173
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Cumulative Exposure to High-Sensitivity C-Reactive Protein Predicts the Risk of Chronic Kidney Diseases.
    Gao J; Wang A; Li X; Li J; Zhao H; Zhang J; Liang J; Chen S; Wu S
    Kidney Blood Press Res; 2020; 45(1):84-94. PubMed ID: 31794962
    [TBL] [Abstract][Full Text] [Related]  

  • 20. High-sensitivity C-reactive protein and the risk of chronic kidney disease progression or acute kidney injury in post-myocardial infarction patients.
    Fu EL; Franko MA; Obergfell A; Dekker FW; Gabrielsen A; Jernberg T; Carrero JJ
    Am Heart J; 2019 Oct; 216():20-29. PubMed ID: 31382219
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.